SIGN UP FOR PERJETA® (PERTUZUMAB) UPDATES
You are now registering for information that is intended for healthcare professionals
By registering at this site, you certify that you are a healthcare professional licensed in the United States or its territories and are indicating that you wish to receive information about PERJETA, other Genentech BioOncology® products, and related disease education. Genentech’s intent is to only provide information to healthcare professionals licensed in the United States or its territories who would likely be treating patients within the FDA-approved indications for this product.
Your request has been received. You will receive PERJETA updates from Genentech. Check your email inbox for a link to manage your subscription.